Veteran private equity and operational leader focused on growth-stage technology and healthcare investments, Katherine Stoner leverages prior operating roles and board experience to source and scale portfolio companies. Known for driving commercial strategy, talent development and buy-and-build execution, she works across capital formation, M&A and governance with an emphasis on revenue expansion and margin improvement in software-enabled services.
Veteran private equity and operational leader focused on growth-stage technology and healthcare investments, Katherine Stoner leverages prior operating roles and board experience to source and scale portfolio companies. Known for driving commercial strategy, talent development and buy-and-build execution, she works across capital formation, M&A and governance with an emphasis on revenue expansion and margin improvement in software-enabled services.
Veteran operator-investor targeting growth-stage software-enabled healthcare and enterprise tech companies. Prioritizes revenue-centric value creation through go-to-market scaling, talent and leadership upgrades, and buy-and-build consolidation to expand margins and market share. Allocates capital into companies with validated product-market fit, recurring revenue and clear paths to unit-economics improvement, favoring active board governance and staged equity with performance-linked milestones. Time horizon is multi-year growth, risk-managed via operational intervention and disciplined follow-on reserve strategy.
Veteran operator-investor targeting growth-stage software-enabled healthcare and enterprise tech companies. Prioritizes revenue-centric value creation through go-to-market scaling, talent and leadership upgrades, and buy-and-build consolidation to expand margins and market share. Allocates capital into companies with validated product-market fit, recurring revenue and clear paths to unit-economics improvement, favoring active board governance and staged equity with performance-linked milestones. Time horizon is multi-year growth, risk-managed via operational intervention and disciplined follow-on reserve strategy.
| Trades 6483 | Longs Won 4682/6483 72% | Profit Factor 10.64 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $24.39M |
| Average Win $2.69M | Best Trade (Aug 17) $1.54B | Sharpe Ratio -113.1 |
| Average Loss -$657,908.91 | Worst Trade (Aug 19) -$73.83M | Z-Score 17.49 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 2w 2d | Expectancy $1.76M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 66,667 | 60,000 | 53,333 | 46,667 | 40,000 | 33,333 | 26,667 | 20,000 | 13,333 | 6,667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2.1M | $359.15M | $633.69M | - | $274.53M | 76.44% | -0.872% |
ABBV AbbVie Inc. | 507,376 | $84.42M | $126.21M | - | $41.79M | 49.5% | -0.532% |
ABT Abbott Laboratories | 934,540 | $96.55M | $103.65M | - | $7.1M | 7.36% | +1.085% |
ACN Accenture plc Class A | 4,561 | $1.24M | $821,618.54 | - | -$415,611.53 | -33.59% | +0.178% |
ACWI iShares MSCI ACWI ETF | 1,314 | $206,259 | $212,408.1 | - | $6,149.1 | 2.98% | +0.472% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 8,290 | $556,208.75 | $644,547.5 | - | $88,338.75 | 15.88% | +0.791% |
ADBE Adobe Inc. | 2,055 | $750,123.58 | $531,731.25 | - | -$218,392.33 | -29.11% | -1.881% |
ADI Analog Devices, Inc. | 629 | $249,820 | $241,806.47 | - | -$8,013.53 | -3.21% | -0.226% |
ADM Archer-Daniels-Midland Co | 1.72M | $117.6M | $137M | - | $19.4M | 16.5% | -0.907% |
ADP Automatic Data Processing Inc. | 6,314 | $1.56M | $1.7M | - | $136,846.86 | 8.75% | -0.649% |
ADSK Autodesk, Inc. | 8,724 | $2.06M | $2.18M | - | $115,817.37 | 5.62% | -0.827% |
AEP American Electric Power Company, Inc. | 883,476 | $81.3M | $110.13M | - | $28.82M | 35.45% | +0.866% |
AES AES Corporation | 31,172 | $410,223.49 | $458,540.12 | - | $48,316.63 | 11.78% | +0.068% |
AFL Aflac Inc. | 3,234 | $267,735.08 | $390,440.82 | - | $122,705.74 | 45.83% | -0.281% |
AGG iShares Core U.S. Aggregate Bond ETF | 51,725 | $5.14M | $5.04M | - | -$103,184.33 | -2.01% | +0.113% |
AGX Argan Inc. | 514 | $279,950 | $294,059.4 | - | $14,109.4 | 5.04% | -1.108% |
AJG Arthur J. Gallagher & Co. | 3,405 | $1.04M | $869,841.3 | - | -$169,281.61 | -16.29% | +0.769% |
AKRE Akre Focus ETF | 13,621 | $892,311.67 | $799,280.28 | - | -$93,031.39 | -10.43% | -1.444% |
ALB Albemarle Corporation | 607,037 | $63.21M | $77.91M | - | $14.7M | 23.25% | -0.788% |
ALL Allstate Corporation | 2,343 | $530,916.78 | $599,433.12 | - | $68,516.34 | 12.91% | -2.437% |